Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population
Authors:
- Li XieLXLi Xie
- Jiangyang ZhaoJZJiangyang Zhao
- Xiuli HuangXHXiuli Huang
- Liuying SongLSLiuying Song
- Jingrong LuoJLJingrong Luo
- Liping MaLMLiping Ma
- Shan LiSLShan Li
- Xue QinXQXue Qin
Open Access
- 1 April 2015
- journal article
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (13) , e702
Abstract
Reactive oxygen species (ROS) play critical roles in hepatocarcinogenesis. The catalase (CAT) enzyme is involved in the repair of ROS. Therefore, we investigate the association between CAT gene polymorphisms and the risk of hepatocellular carcinoma (HCC). A total of 715 subjects were divided into 4 groups: 111 chronic hepatitis B (CHB) patients, 90 hepatitis B virus (HBV)-related liver cirrhosis (LC) patients, 266 HBV-HCC patients, and 248 healthy controls. The polymerase chain reaction-restriction fragment length polymorphism strategy was used to detect CAT gene rs1001179, rs769217, and rs7943316 polymorphisms. Binary logistic regression analyses adjusting for sex, age, ethnicity, smoking and alcohol consumption, and body mass index suggested that subjects carrying the rs769217 T allele were at marginally increased risk of CHB, LC, and HCC, with adjusted odds ratios (ORs) of 1.51 (95% confidence interval [CI] = 1.04-2.20, P = 0.029), 1.48 (95% CI = 1.03-2.14, P = 0.035), and 1.51 (95% CI = 1.14-1.98, P = 0.004), respectively. Similarly, those individuals carrying the rs769217 TT genotype had a moderately increased risk of CHB, LC, and HCC, with adjusted ORs of 2.11 (95% CI = 1.05-4.22, P = 0.035), 2.00 (95% CI, 1.01-3.95, P = 0.047), and 1.93 (95% CI = 1.14-3.28, P = 0.015), respectively. Moreover, subjects carrying the rs769217 CT genotype and at least 1 copy of the T allele (dominant model) were 1.78 times and 1.83 times more likely to develop HCC, respectively (OR = 1.78, 95% CI = 1.16-2.73, P = 0.009 and OR = 1.83, 95% CI = 1.23-2.71, P = 0.003). This association between CAT rs769217 T alleles and HCC risk is significantly strengthened among men, nonsmokers, nondrinkers, and among individuals <50 years of age. Furthermore, we found 1 high-risk haplotype GTA for CHB (OR = 1.45, 95% CI = 1.05-2.01) and 1 protective haplotype GCA for HCC risk (OR = 0.67, 95% CI = 0.52-0.87). We did not found any significant difference in CAT rs1001179 and rs7943316 polymorphisms between controls and cases. Our findings suggest that the CAT rs769217 T allele is associated with increased risk of CHB, HBV-LC, and HBV-HCC in Guangxi population.Keywords
This publication has 35 references indexed in Scilit:
- Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case–control studyCancer Causes & Control, 2012
- The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker developmentChemico-Biological Interactions, 2010
- Polymorphisms in antioxidant defence genes and susceptibility to hepatocellular carcinoma in a Moroccan populationFree Radical Research, 2009
- Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis #Hepatology, 2009
- Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitusBMC Medical Genetics, 2008
- Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean populationExperimental Dermatology, 2006
- Age-dependent imbalance of the antioxidative system in human satellite cellsExperimental Gerontology, 2005
- Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAsCell Research, 2005
- SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism lociCell Research, 2005
- Reversible inhibition and irreversible inactivation of catalase in presence of hydrogen peroxideBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1996